Literature DB >> 7453105

[Primary amyloidosis with nephrotic syndrome: 5 year follow-up under polychemotherapy. A case report (author's transl)].

B Emmerich, A Kircher, U Fink, L Schmid, J Rastetter.   

Abstract

A patient with primary amyloidosis had infiltration of liver, bone and bone marrow and a nephrotic syndrome with massive proteinuria. In addition, there was evidence for a plasma cell dyscrasia with an increased number of plasma cells and other lymphoreticular cell elements in the bone marrow and an impairment of immunoglobulin synthesis without M-gradient. The course of disease was observed over a period of five years. The patient was treated intermittently with a combination of penicillamine, melphalan, fluocortolone and fluoxymesterone. Under treatment the nephrotic syndrome disappeared and liver size decreased. Hemopoiesis remained sufficient but bone marrow infiltration by amyloid did not respond to therapy and massive osteoporosis developed. Comparison of our with other reported cases treated with the same regime suggests that response to this treatment may be influenced by factors such as sex and clinical manifestation of the disease.

Entities:  

Mesh:

Year:  1980        PMID: 7453105     DOI: 10.1007/bf01478877

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  19 in total

1.  [What is the relation between the various forms of amyloidosis and the connective tissue fibers?].

Authors:  H P MISSMAHL
Journal:  Verh Dtsch Ges Inn Med       Date:  1959

2.  Renal transplantation in two cases of amyloidosis.

Authors:  A S Cohen; A B Bricetti; J T Harrington; J A Mannick
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

Review 3.  A clinical analysis of the course and prognosis of forty-two patients with amyloidosis.

Authors:  K Brandt; E S Cathcart; A S Cohen
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

4.  Renal amyloidosis--a fourteen-year follow-up.

Authors:  D R Triger; A M Joekes
Journal:  Q J Med       Date:  1973-01

5.  [Treatment of amyloidoses].

Authors:  H P Missmahl
Journal:  Dtsch Med Wochenschr       Date:  1969-12-26       Impact factor: 0.628

6.  Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.

Authors:  R Alexanian; A Haut; A U Khan; M Lane; E M McKelvey; P J Migliore; W J Stuckey; H E Wilson
Journal:  JAMA       Date:  1969-06-02       Impact factor: 56.272

7.  Combination chemotherapy for primary amyloidosis reconsidered.

Authors:  H J Cohen
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

8.  Amyloidosis: review of 236 cases.

Authors:  R A Kyle; E D Bayrd
Journal:  Medicine (Baltimore)       Date:  1975-07       Impact factor: 1.889

9.  The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia.

Authors:  D E Bergsagel; A J Bailey; G R Langley; R N MacDonald; D F White; A B Miller
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

10.  Chemical classes of amyloid substance.

Authors:  E P Benditt; N Eriksen
Journal:  Am J Pathol       Date:  1971-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.